Loading company details…
ILLUMERX LTD develops patented technology for the reconstitution of lyophilized and powdered pharmac Sign up to read more
Profile updated Jul 2026
No share issues or funding rounds.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| THOMAS EDWARDS | ORDINARY | 1,000 | 100.0% |
Companies with the most similar business descriptions.
Capital raised per employee divides the equity ILLUMERX LTD raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.